Appro Therapeutics

Asserta-B is a personalized cancer therapy that when coupled with its related companion diagnostic, ensures that the patient is receiving the appropriate care.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Louisville, KY, US
  • Currency USD
  • Founded 2013
  • Website ApproTherapeutics.com

Company Summary

Appro Therapeutics presents Asserta-B, a novel cancer therapeutic, along with a companion biomarker to predict patient response, with demonstrated effectiveness in destroying SOX9 overexpressing cancer cells. SOX9 is overexpressed in up to 50% of the most common cancers.

Team

  • Will Morris

  • Melissa Buddeke

  • Jordan Davis

  • Chris Barton

  • Divya Jagadish

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free